SPOP is the most frequently mutated gene in primary prostate cancer (PCa) and its mutation rate ranges from 10 to 15% of human PCa depending on the patient cohorts studied (Barbieri et al, 2012; Cancer Genome Atlas Research Network, 2015). The gene discussed is SPOP; the disease is posterior cortical atrophy.